ZA200705383B - Benzoyl-tetrahydropyridine as GlyT-1 inhibitors - Google Patents
Benzoyl-tetrahydropyridine as GlyT-1 inhibitorsInfo
- Publication number
- ZA200705383B ZA200705383B ZA200705383A ZA200705383A ZA200705383B ZA 200705383 B ZA200705383 B ZA 200705383B ZA 200705383 A ZA200705383 A ZA 200705383A ZA 200705383 A ZA200705383 A ZA 200705383A ZA 200705383 B ZA200705383 B ZA 200705383B
- Authority
- ZA
- South Africa
- Prior art keywords
- glyt
- tetrahydropyridine
- benzoyl
- inhibitors
- Prior art date
Links
- BECCUPAXNMKZJU-UHFFFAOYSA-N 3,4-dihydro-2h-pyridin-1-yl(phenyl)methanone Chemical compound C=1C=CC=CC=1C(=O)N1CCCC=C1 BECCUPAXNMKZJU-UHFFFAOYSA-N 0.000 title 1
- 102100023145 Sodium- and chloride-dependent glycine transporter 1 Human genes 0.000 title 1
- 101710083171 Sodium- and chloride-dependent glycine transporter 1 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05100027 | 2005-01-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200705383B true ZA200705383B (en) | 2008-09-25 |
Family
ID=36118130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200705383A ZA200705383B (en) | 2005-01-04 | 2007-07-02 | Benzoyl-tetrahydropyridine as GlyT-1 inhibitors |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7485637B2 (ru) |
| EP (1) | EP1836168B1 (ru) |
| JP (1) | JP4738421B2 (ru) |
| KR (1) | KR100957280B1 (ru) |
| CN (1) | CN101111477B (ru) |
| AR (1) | AR052553A1 (ru) |
| AT (1) | ATE423770T1 (ru) |
| AU (1) | AU2005324109B2 (ru) |
| BR (1) | BRPI0519746A2 (ru) |
| CA (1) | CA2594260A1 (ru) |
| DE (1) | DE602005012997D1 (ru) |
| ES (1) | ES2319220T3 (ru) |
| IL (1) | IL184206A (ru) |
| MX (1) | MX2007008043A (ru) |
| NO (1) | NO20073275L (ru) |
| RU (1) | RU2007124546A (ru) |
| TW (1) | TW200635898A (ru) |
| WO (1) | WO2006072432A1 (ru) |
| ZA (1) | ZA200705383B (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0713584A2 (pt) * | 2006-06-22 | 2012-10-23 | Hoffmann La Roche | derivados de fenil metanona substituìda |
| JP6034215B2 (ja) * | 2013-02-19 | 2016-11-30 | 株式会社東芝 | 紙葉類処理装置 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2423847A1 (de) * | 1973-05-28 | 1975-01-02 | Ciba Geigy Ag | Neue sulfamoylbenzoesaeureamide |
| DE2533604A1 (de) | 1975-07-26 | 1977-02-10 | Bayer Ag | 2-substituierte 5-trifluormethyl1,3,4-thiadiazole, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und insektizide |
| DE2611705A1 (de) * | 1976-03-18 | 1977-09-22 | Josef Dipl Chem Dr Rer N Klosa | N-5-(nitrofurfuryliden-)-1-amino- hydantoin enthaltende kristalloesungsmittel |
| US4122083A (en) * | 1978-01-16 | 1978-10-24 | E. R. Squibb & Sons, Inc. | 1,2,3,4-Tetrahydropyrido[4',3':4.5]thiazolo-[3,2-a]benzimidazoles |
| US4436002A (en) | 1981-12-11 | 1984-03-13 | Hughes Tool Company | Reversal mechanism for power tong |
| IT1176613B (it) | 1984-08-14 | 1987-08-18 | Ravizza Spa | Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione |
| RU2124511C1 (ru) | 1993-05-14 | 1999-01-10 | Фармасьютикал Ко., Лтд | Производные пиперазина |
| TW498067B (en) * | 1996-07-19 | 2002-08-11 | Hoffmann La Roche | 4-hydroxy-piperidine derivatives |
| BR9907951A (pt) | 1998-03-06 | 2001-01-30 | Janssen Pharmaceutica Nv | Inibidores de transporte de glicina |
| CA2322136A1 (en) | 1998-03-06 | 1999-09-10 | Ludo Edmond Josephine Kennis | Glycine transport inhibitors |
| US20030216385A1 (en) * | 2000-05-19 | 2003-11-20 | Takahiko Tobe | Triazole derivatives |
| GB0021419D0 (en) | 2000-08-31 | 2000-10-18 | Oxford Glycosciences Uk Ltd | Compounds |
| GB0106661D0 (en) | 2001-03-16 | 2001-05-09 | Pfizer Ltd | Pharmaceutically active compounds |
| ATE449090T1 (de) | 2001-07-02 | 2009-12-15 | High Point Pharmaceuticals Llc | Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren |
| WO2003035602A1 (fr) | 2001-10-25 | 2003-05-01 | Sankyo Company, Limited | Modulateurs lipidiques |
| IL161966A0 (en) * | 2001-12-20 | 2005-11-20 | Lundbeck & Co As H | Aryloxyphenyl and arylsulfanylphenyl |
| AU2003274053A1 (en) | 2002-10-22 | 2004-05-13 | Glaxo Group Limited | Aryloxyalkylamine derivates as h3 receptor ligands |
| EP1594840B1 (en) * | 2003-02-17 | 2006-09-27 | F. Hoffmann-La Roche Ag | Piperidine-benzenesulfonamide derivatives |
| KR100774622B1 (ko) * | 2003-08-11 | 2007-11-08 | 에프. 호프만-라 로슈 아게 | Ｏｒ-치환된 페닐 그룹을 갖는 피페라진 및 ｇｌｙｔ1억제제로서 그의 용도 |
| JP4563387B2 (ja) * | 2003-09-09 | 2010-10-13 | エフ．ホフマン−ラ ロシュ アーゲー | 精神病の処置のためのグリシン取り込み阻害剤としての１−ベンゾイル−ピペラジン誘導体 |
| DK1663232T3 (da) * | 2003-09-09 | 2008-02-04 | Hoffmann La Roche | Benzimidazolderivater som human chymase-inhibitorer |
| ATE430142T1 (de) * | 2004-12-09 | 2009-05-15 | Hoffmann La Roche | Phenylpiperazin-methanon-derivate |
| DE602005019465D1 (de) * | 2004-12-15 | 2010-04-01 | Hoffmann La Roche | Bi- und trizyklische substituierte phenyl-methanone als inhibitoren von glycin-i (glyt-1)-transportern zur behandlung der alzheimer-krankheit |
| WO2007060408A2 (en) * | 2005-11-23 | 2007-05-31 | Astrazeneca Ab | L-phenylalanine derivatives and their use as integrin antagonists |
-
2005
- 2005-12-13 US US11/302,403 patent/US7485637B2/en not_active Expired - Fee Related
- 2005-12-27 CN CN2005800476568A patent/CN101111477B/zh not_active Expired - Fee Related
- 2005-12-27 RU RU2007124546/04A patent/RU2007124546A/ru not_active Application Discontinuation
- 2005-12-27 AT AT05820269T patent/ATE423770T1/de active
- 2005-12-27 ES ES05820269T patent/ES2319220T3/es active Active
- 2005-12-27 JP JP2007549822A patent/JP4738421B2/ja not_active Expired - Fee Related
- 2005-12-27 AU AU2005324109A patent/AU2005324109B2/en not_active Ceased
- 2005-12-27 KR KR1020077017900A patent/KR100957280B1/ko not_active IP Right Cessation
- 2005-12-27 CA CA002594260A patent/CA2594260A1/en not_active Abandoned
- 2005-12-27 WO PCT/EP2005/014052 patent/WO2006072432A1/en active Application Filing
- 2005-12-27 BR BRPI0519746-5A patent/BRPI0519746A2/pt not_active IP Right Cessation
- 2005-12-27 MX MX2007008043A patent/MX2007008043A/es active IP Right Grant
- 2005-12-27 DE DE602005012997T patent/DE602005012997D1/de active Active
- 2005-12-27 EP EP05820269A patent/EP1836168B1/en not_active Not-in-force
-
2006
- 2006-01-02 TW TW095100092A patent/TW200635898A/zh unknown
- 2006-01-03 AR ARP060100011A patent/AR052553A1/es unknown
-
2007
- 2007-06-25 IL IL184206A patent/IL184206A/en active IP Right Grant
- 2007-06-27 NO NO20073275A patent/NO20073275L/no not_active Application Discontinuation
- 2007-07-02 ZA ZA200705383A patent/ZA200705383B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101111477A (zh) | 2008-01-23 |
| EP1836168A1 (en) | 2007-09-26 |
| IL184206A (en) | 2011-09-27 |
| RU2007124546A (ru) | 2009-02-20 |
| JP2008526794A (ja) | 2008-07-24 |
| WO2006072432A1 (en) | 2006-07-13 |
| EP1836168B1 (en) | 2009-02-25 |
| ES2319220T3 (es) | 2009-05-05 |
| IL184206A0 (en) | 2007-10-31 |
| TW200635898A (en) | 2006-10-16 |
| JP4738421B2 (ja) | 2011-08-03 |
| KR100957280B1 (ko) | 2010-05-12 |
| AU2005324109B2 (en) | 2011-01-20 |
| DE602005012997D1 (de) | 2009-04-09 |
| AU2005324109A1 (en) | 2006-07-13 |
| AR052553A1 (es) | 2007-03-21 |
| CA2594260A1 (en) | 2006-07-13 |
| BRPI0519746A2 (pt) | 2009-03-10 |
| ATE423770T1 (de) | 2009-03-15 |
| US20060148797A1 (en) | 2006-07-06 |
| MX2007008043A (es) | 2007-07-16 |
| NO20073275L (no) | 2007-07-31 |
| CN101111477B (zh) | 2010-05-26 |
| US7485637B2 (en) | 2009-02-03 |
| KR20070094953A (ko) | 2007-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200707650B (en) | Azolylacylguanidines as ß-secretase inhibitors | |
| HK1116776A1 (en) | Triazolophthalazines as pde2-inhibitors | |
| AP2108A (en) | Novel biphenylsulfonamides | |
| IL184303A0 (en) | Amino-pyridines as inhibitors of ??-secretase | |
| AP2007004171A0 (en) | Novel compounds | |
| EP1944301A4 (en) | NEW BENZOXATHIIN DERIVATIVES | |
| EP1868612A4 (en) | NOVEL CONNECTIONS | |
| EP1868611A4 (en) | NOVEL CONNECTIONS | |
| GB0512429D0 (en) | Novel compound | |
| EP1869026A4 (en) | NEW CONNECTIONS | |
| IL196807A0 (en) | Inhibitors for glyt-1 | |
| ZA200705383B (en) | Benzoyl-tetrahydropyridine as GlyT-1 inhibitors | |
| GB0500140D0 (en) | Novel compounds | |
| GB0516967D0 (en) | Inhibitors | |
| EP1961756A4 (en) | NEW BISBORNET CONNECTION | |
| GB0506443D0 (en) | Novel inhibitors | |
| GB0522071D0 (en) | Novel compound | |
| GB0525350D0 (en) | Novel compound | |
| GB0517908D0 (en) | Novel split-nucleosides | |
| GB0508694D0 (en) | Novel methods | |
| GB0503128D0 (en) | Novel Uses | |
| GB0503125D0 (en) | Novel uses | |
| GB0503124D0 (en) | Novel uses | |
| GB0500884D0 (en) | Novel compounds | |
| GB0500887D0 (en) | Novel compounds |